Prognostic Value of Advanced Lung Cancer Inflammation Index in Heart Failure Patients: A Comprehensive Analysis
Prognostischer Wert des Advanced Lung Cancer Inflammation Index bei Patient:innen mit Herzinsuffizienz: eine umfassende Analyse
ESC Heart Failure · 01.06.2025 · 12 (3) · 2298-2309
DOI: 10.1002/ehf2.15178 ↗Auf einen Blick
In zwei Analysen war ein höherer ALI bei Herzinsuffizienz mit günstigerem Langzeitverlauf und mit strukturellen Veränderungen des Herzens assoziiert. Die Autoren berichten Zusammenhänge zu Mortalität und linksventrikulärem Reverse Remodelling.
Fragestellung
Welchen prognostischen Wert hat der Advanced Lung Cancer Inflammation Index (ALI) bei Patient:innen mit Herzinsuffizienz?
Methode
Studie 1 mit 1.359 HF-Patient:innen aus NHANES 1999–2018; Studie 2 mit HF-Patient:innen mit kardialer MRT 2020–2023. Kaplan-Meier, Cox-Modelle, ROC, RCS, logistische Regression und Spearman-Korrelation.
Ergebnisse
Studie 1: 699 Gesamtsterblichkeits- und 293 kardiovaskuläre Todesfälle. Höherer ALI war mit geringeren Risiken für Gesamtsterblichkeit (HR 0,58; 95 %-KI 0,42–0,79) und kardiovaskuläre Mortalität (HR 0,61; 95 %-KI 0,38–0,97) assoziiert. Studie 2: ALI und LVRR (OR 3,16; 95 %-KI 1,06–10,8).
Schlussfolgerung der Autor:innen
ALI ist bei Patient:innen mit Herzinsuffizienz mit dem Risiko für Gesamt- und kardiovaskuläre Mortalität sowie mit strukturellen Herzveränderungen assoziiert.
Kernaussagen
- ALI war mit Gesamtsterblichkeit und kardiovaskulärer Mortalität assoziiert.
- Höherer ALI zeigte in Studie 2 eine Assoziation mit LVRR.
- ALI korrelierte mit ECV (r = −0,25).
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift ESC Heart Failure, online erschienen am 03.12.2024. Verfasst von Wentao Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory for Innovation and Transformation of Luobing Theory; The Key Laboratory of Cardiovascular Remodeling and Function Research, C…. Hauptthemen laut MEDLINE: Heart Failure, Lung Neoplasms, Inflammation. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key Technologies Research and Development Program, Taishan Scholars Program of Shandong Province, Shandong Provincial Natural Science Foundation.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Aims
The prognosis of heart failure (HF) is closely linked to inflammation and nutritional status. The advanced lung cancer inflammation index (ALI) is a composite indicator consisting of several parameters used to assess inflammation and nutritional status. Our study aimed to investigate the prognostic value of ALI in HF patients.
Methods
The data from Study 1, which included 1359 HF patients, were extracted from the National Health and Nutrition Examination Survey (NHANES) database spanning the years 1999 to 2018. Study 2 analysed data from patients with HF who underwent cardiac magnetic resonance imaging examinations from 2020 to 2023. Kaplan–Meier curve analysis, Cox proportional hazard model, time-dependent receiver operating characteristic (ROC) curve and restricted cubic spline (RCS) were used to evaluate the relationship between ALI and long-term prognosis of patients with HF in Study 1. Logistic regression analysis was used to evaluate the correlation between ALI and left ventricular reverse remodelling, and RCS was used to determine any dose–response relationship. Spearman correlation was used to evaluate the relationship between ALI and indicators of cardiac structural changes.
Results
Study 1 found that the average age of the patients was 68 years [inter-quartile range (IQR) 58–76], the proportion of males was 54.3%, and there were 699 all-cause mortality and 293 cardiovascular mortality cases. After adjusted by multivariable Cox regression analysis, elevated ALI levels were significantly associated with increased risks of all-cause [hazard ratio (HR) = 0.58, 95% confidence interval (CI) = 0.42–0.79, P < 0.001] and cardiovascular mortality (HR = 0.61, 95% CI = 0.38–0.97, P = 0.036) in patients with HF. A linear negative correlation was observed between ALI and both all-cause (P = 0.0011 and P < 0.001, P for nonlinear = 0.3993) and cardiovascular mortality (P = 0.0011, P for nonlinear = 0.5198). Time-dependent ROC curves showed the predictive value of ALI for all-cause mortality [area under the curve (AUC) = 0.678 in 3 years, AUC = 0.674 in 5 years and AUC = 0.683 in 10 years] and cardiovascular mortality (AUC = 0.694 in 3 years, AUC = 0.685 in 5 years and AUC = 0.697 in 10 years). Study 2 included 79 patients; the average age of the patients was 44 years (IQR 35–55); and the proportion of males was 74.7%. Adjusted multivariable logistic regression analysis indicated that high ALI levels were associated with left ventricular reverse remodelling (LVRR) in patients with HF following discharge from the hospital [odds ratio (OR) = 3.16, 95% CI = 1.06–10.8, P = 0.049]. Spearman analysis revealed a correlation between ALI and extracellular volume (ECV) (r = −0.25, P = 0.023).
Conclusion
ALI is associated with all-cause and cardiovascular mortality risk and structural changes in the heart in patients with HF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Key Laboratory for Innovation and Transformation of Luobing Theory; The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and C…
ORCID-Profile: Huixia Lu
Förderung
- Key Technologies Research and Development Program
- Taishan Scholars Program of Shandong Province
- Shandong Provincial Natural Science Foundation
- Natural Science Foundation of Shandong Province
Zitieren
APA
Chen, W., Zhang, G., Lei, Q., & Lu, H. (2025). Prognostic Value of Advanced Lung Cancer Inflammation Index in Heart Failure Patients: A Comprehensive Analysis. ESC Heart Failure, 12(3), 2298-2309. https://doi.org/10.1002/ehf2.15178
Vancouver
Chen W, Zhang G, Lei Q, Lu H. Prognostic Value of Advanced Lung Cancer Inflammation Index in Heart Failure Patients: A Comprehensive Analysis. ESC Heart Failure. 2025;12(3):2298-2309. doi:10.1002/ehf2.15178
BibTeX
@article{Chen2025,
author = {Chen, Wentao and Zhang, Guihua and Lei, Qiao and Lu, Huixia},
title = {Prognostic Value of Advanced Lung Cancer Inflammation Index in Heart Failure Patients: A Comprehensive Analysis},
journal = {ESC Heart Failure},
year = {2025},
volume = {12},
number = {3},
pages = {2298--2309},
doi = {10.1002/ehf2.15178}
}
EUVIMED